Lv7
4320 积分 2021-11-18 加入
Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C Study
1个月前
已完结
Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial
1个月前
已完结
BBO-10203 inhibits tumor growth without inducing hyperglycemia by blocking RAS-PI3Kα interaction
2个月前
已完结
A neomorphic protein interface catalyzes covalent inhibition of RAS G12D aspartic acid in tumors
2个月前
已完结
The non-small-cell lung cancer drug market
2个月前
已完结
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2个月前
已完结
Advancing cancer research via comparative oncology
3个月前
已完结
Cancer treatment paradigms in the precision medicine era
4个月前
已完结
Next-generation KRAS-G12C inhibitor D3S-001 shows promise
4个月前
已关闭
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
5个月前
已完结
Clinical and Genomic Features of HER2 Exon 20 Insertion Mutations and Characterization of HER2 Expression by Immunohistochemistry in East Asian Non–Small-Cell Lung Cancer
皖公网安备34019202002308
